Zobrazeno 1 - 10
of 40
pro vyhledávání: '"drug-eluting stents/adverse effects"'
Autor:
Coughlan, J J, Räber, Lorenz, Brugaletta, Salvatore, Kufner, Sebastian, Maeng, Michael, Jensen, Lisette Okkels, Ortega-Paz, Luis, Bär, Sarah, Laugwitz, Karl-Ludwig, Madsen, Morten, Heg, Dik, Aytekin, Alp, Windecker, Stephan, Olesen, Kevin Kris Warnakula, Sabaté, Manel, Kastrati, Adnan, Cassese, Salvatore
Publikováno v:
Coughlan, J J, Räber, L, Brugaletta, S, Kufner, S, Maeng, M, Jensen, L O, Ortega-Paz, L, Bär, S, Laugwitz, K-L, Madsen, M, Heg, D, Aytekin, A, Windecker, S, Olesen, K K W, Sabaté, M, Kastrati, A & Cassese, S 2023, ' Sex Differences in 10-Year Outcomes After Percutaneous Coronary Intervention With Drug-Eluting Stents : Insights From the DECADE Cooperation ', Circulation, vol. 147, no. 7, pp. 575-585 . https://doi.org/10.1161/CIRCULATIONAHA.122.062049
Background: Although some studies have investigated sex-related outcomes up to 5 years after percutaneous coronary intervention (PCI), analyses at longer follow-up (ie, to 10 years) in large cohorts treated exclusively with drug-eluting stent (DES) p
Autor:
Lars Jakobsen, Evald H. Christiansen, Phillip Freeman, Johnny Kahlert, Karsten Veien, Michael Maeng, Bent Raungaard, Julia Ellert, Steen D. Kristensen, Martin K. Christensen, Christian J. Terkelsen, Troels Thim, Ashkan Eftekhari, Rebekka V. Jensen, Nicolaj B. Støttrup, Anders Junker, Henrik S. Hansen, Lisette O. Jensen
Publikováno v:
Jakobsen, L, Christiansen, E H, Freeman, P, Kahlert, J, Veien, K, Maeng, M, Raungaard, B, Ellert, J, Kristensen, S D, Christensen, M K, Terkelsen, C J, Thim, T, Eftekhari, A, Jensen, R V, Støttrup, N B, Junker, A, Hansen, H S & Jensen, L O 2023, ' Impact of acute coronary syndrome on clinical outcomes after revascularization with the dual-therapy CD34 antibody-covered sirolimus-eluting Combo stent and the sirolimus-eluting Orsiro stent ', Catheterization and Cardiovascular Interventions, vol. 101, no. 1, pp. 13-21 . https://doi.org/10.1002/ccd.30480
OBJECTIVES: To compare the efficacy and safety of the dual-therapy CD34 antibody-covered sirolimus-eluting Combo stent (DTS) and the sirolimus-eluting Orsiro stent (O-SES) in patients with and without acute coronary syndrome (ACS) included in the SOR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6a328322cab723340935d6d4ac01587
https://pure.au.dk/portal/da/publications/impact-of-acute-coronary-syndrome-on-clinical-outcomes-after-revascularization-with-the-dualtherapy-cd34-antibodycovered-sirolimuseluting-combo-stent-and-the-sirolimuseluting-orsiro-stent(f41888cf-79e5-49c0-9b19-4854f821239d).html
https://pure.au.dk/portal/da/publications/impact-of-acute-coronary-syndrome-on-clinical-outcomes-after-revascularization-with-the-dualtherapy-cd34-antibodycovered-sirolimuseluting-combo-stent-and-the-sirolimuseluting-orsiro-stent(f41888cf-79e5-49c0-9b19-4854f821239d).html
Autor:
Julia Ellert-Gregersen, Lisette Jensen Jensen, Lars Jakobsen, Phillip Michael Freeman, Ashkan Eftekhari, Michael Maeng, Bent Raungaard, Thomas Engstroem, Johnny Kahlert, Henrik Hansen Hansen, Evald Høj Christiansen
Publikováno v:
Ellert-Gregersen, J, Jensen, L O, Jakobsen, L, Freeman, P M, Eftekhari, A, Maeng, M, Raungaard, B, Engstroem, T, Kahlert, J, Hansen, H S & Christiansen, E H 2022, ' Polymer-free biolimus-coated stents versus ultrathin-strut biodegradable polymer sirolimus-eluting stents : two-year outcomes of the randomised SORT OUT IX trial ', EuroIntervention, vol. 18, no. 2, pp. e124-e131 . https://doi.org/10.4244/EIJ-D-21-00874
EuroIntervention
EuroIntervention
BACKGROUND: For patients with high bleeding risk, the BioFreedom stent is safer and more effective than a bare metal stent. However, at the one-year follow-up of the SORT OUT IX trial, the BioFreedom stent did not meet the criteria for non-inferiorit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8162816a489c072dd7fea9ad3789a72
https://pure.au.dk/portal/da/publications/polymerfree-biolimuscoated-stents-versus-ultrathinstrut-biodegradable-polymer-sirolimuseluting-stents(07ecf6dc-431f-42d3-8eb5-c856a0781da8).html
https://pure.au.dk/portal/da/publications/polymerfree-biolimuscoated-stents-versus-ultrathinstrut-biodegradable-polymer-sirolimuseluting-stents(07ecf6dc-431f-42d3-8eb5-c856a0781da8).html
Autor:
Otmar Pfister, Matthias Pfisterer, Gregor Fahrni, Marco E. G. V. Cattaneo, David Conen, Michael Coslovsky, Thomas Engstrøm, Sven Möbius-Winkler, Raphael Twerenbold, Søren Galatius, Ahmed Farah, Franz R. Eberli, Gerhard Schuler, Christian Mueller, Christoph Kaiser, Peter Rickenbacher, Raban Jeger, Norman Mangner
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Fahrni, G, Farah, A, Engstrøm, T, Galatius, S, Eberli, F, Rickenbacher, P, Conen, D, Mueller, C, Pfister, O, Twerenbold, R, Coslovsky, M, Cattaneo, M, Kaiser, C, Mangner, N, Schuler, G, Pfisterer, M, Möbius-Winkler, S, Jeger, R V & BASKET-SAVAGE-Investigators* 2020, ' Long-Term Results After Drug-Eluting Versus Bare-Metal Stent Implantation in Saphenous Vein Grafts : Randomized Controlled Trial ', Journal of the American Heart Association, vol. 9, no. 20, e017434 . https://doi.org/10.1161/JAHA.120.017434
Fahrni, G, Farah, A, Engstrøm, T, Galatius, S, Eberli, F, Rickenbacher, P, Conen, D, Mueller, C, Pfister, O, Twerenbold, R, Coslovsky, M, Cattaneo, M, Kaiser, C, Mangner, N, Schuler, G, Pfisterer, M, Möbius-Winkler, S, Jeger, R V & BASKET-SAVAGE-Investigators* 2020, ' Long-Term Results After Drug-Eluting Versus Bare-Metal Stent Implantation in Saphenous Vein Grafts : Randomized Controlled Trial ', Journal of the American Heart Association, vol. 9, no. 20, e017434 . https://doi.org/10.1161/JAHA.120.017434
Background Efficacy data on drug‐eluting stents (DES) versus bare‐metal stents (BMS) in saphenous vein grafts are controversial. We aimed to compare DES with BMS among patients undergoing saphenous vein grafts intervention regarding long‐term o
Publikováno v:
Arquivos Brasileiros de Cardiologia
Arquivos Brasileiros de Cardiologia, Vol 110, Iss 3, Pp 207-210
Arquivos Brasileiros de Cardiologia, Vol 110, Iss 3, Pp 207-210
As arboviroses constituem um importante problema de saude publica especialmente em paises de regioes tropical e subtropical, como o Brasil. Nesses locais, predominam os virus das familias Flaviviridae, responsaveis pela Dengue, Zika e Febre Amarela (
Autor:
Xiao-Ping Zhang, Lu Shoutao, Haijun Zhang, Wei Deng, Duan Cuihai, Fei Yang, Junbo Ge, Hou Wenbo, Chao Zhou, Yin Yuxia, Shenguo Wang, Cui Xiaoshan, Liu Guang, Song Caixia, Zhang Junwei
Publikováno v:
Zhang, H, Zhang, X, Yin, Y, Zhou, C, Deng, W, Zhang, J, Hou, W, Lu, S, Song, C, Cui, X, Wang, S, Yang, F, Liu, G, Duan, C & Ge, J 2019, ' An abluminal biodegradable polymer sirolimus-eluting stent versus a durable polymer everolimus-eluting stent in patients undergoing coronary revascularization : 3-year clinical outcomes of a randomized non-inferiority trial ', Scientific Reports, vol. 9, no. 1, 18549 . https://doi.org/10.1038/s41598-019-54964-8
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-10 (2019)
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-10 (2019)
The Cordimax stent has proved non-inferior to the Cypher Select durable polymer sirolimus-eluting stent for the primary endpoint of angiographic in-stent late luminal loss and in-stent mean diameter stenosis at 9 months. The trial was designed to com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a65fdb51fe9ebc5c81f2b0617655cb25
https://vbn.aau.dk/da/publications/f5b70457-c6c9-4421-8a92-4fa8f55309f8
https://vbn.aau.dk/da/publications/f5b70457-c6c9-4421-8a92-4fa8f55309f8
Autor:
Philipp Jakob, Roland Klingenberg, François Mach, Ulf Landmesser, Baris Gencer, Willibald Maier, Lorenz Räber, Stephan Windecker, Christian M. Matter, Barbara E. Stähli, Thomas F. Lüscher, David Nanchen, Dik Heg, Manfred Wischnewsky, Slayman Obeid, Peter Jüni
Publikováno v:
Catheterization and Cardiovascular Interventions, Vol. 93, No 1 (2019) pp. 16-24
OBJECTIVES The number of elderly patients undergoing coronary revascularization is steadily increasing, and data on the impact of gender on outcomes are scarce. This study sought to assess gender-related differences in outcomes in elderly patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9376cae5ce09e827b5ba270d58ab741
Publikováno v:
Arquivos Brasileiros de Cardiologia, Volume: 110, Issue: 3, Pages: 207-210, Published: MAR 2018
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______608::1f08e45baad6ac9fa1c5011eae7b022f
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2018000300207&lng=en&tlng=en
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2018000300207&lng=en&tlng=en
Autor:
Christian Gluud, Janette Greenhalgh, Joshua Feinberg, Sanam Safi, Janus Christian Jakobsen, Juliet Hounsome, Naqash J Sethi, Emil Eik Nielsen
Publikováno v:
The Cochrane Library
Feinberg, J, Nielsen, E E, Greenhalgh, J, Hounsome, J, Sethi, N J, Safi, S, Gluud, C & Jakobsen, J C 2016, ' Drug-eluting stents versus bare-metal stents for acute coronary syndrome ', Cochrane Database of Systematic Reviews, vol. 2016, no. 12, CD012481 . https://doi.org/10.1002/14651858.CD012481
Feinberg, J, Nielsen, E E, Greenhalgh, J, Hounsome, J, Sethi, N J, Safi, S, Gluud, C & Jakobsen, J C 2017, ' Drug-eluting stents versus bare-metal stents for acute coronary syndrome ', Cochrane Database of Systematic Reviews, vol. 2017, no. 8, CD012481 . https://doi.org/10.1002/14651858.CD012481.pub2
Feinberg, J, Nielsen, E E, Greenhalgh, J, Hounsome, J, Sethi, N J, Safi, S, Gluud, C & Jakobsen, J C 2016, ' Drug-eluting stents versus bare-metal stents for acute coronary syndrome ', Cochrane Database of Systematic Reviews, vol. 2016, no. 12, CD012481 . https://doi.org/10.1002/14651858.CD012481
Feinberg, J, Nielsen, E E, Greenhalgh, J, Hounsome, J, Sethi, N J, Safi, S, Gluud, C & Jakobsen, J C 2017, ' Drug-eluting stents versus bare-metal stents for acute coronary syndrome ', Cochrane Database of Systematic Reviews, vol. 2017, no. 8, CD012481 . https://doi.org/10.1002/14651858.CD012481.pub2
Background Approximately 3.7 million people died from acute coronary syndrome worldwide in 2012. Acute coronary syndrome, also known as myocardial infarction or unstable angina pectoris, is caused by a sudden blockage of the blood supplied to the hea
Autor:
Troels Thim, Michael Maeng, Morten Madsen, Lisette Okkels Jensen, Kevin Kris Warnakula Olesen, Steen Dalby Kristensen, Hans Erik Bøtker, Henrik Toft Sørensen, Gro Egholm, Svend Eggert Jensen
Publikováno v:
Egholm, G, Kristensen, S D, Thim, T, Olesen, K K W, Madsen, M, Jensen, S E, Jensen, L O, Sørensen, H T, Bøtker, H E & Maeng, M 2016, ' Risk Associated With Surgery Within 12 Months After Coronary Drug-Eluting Stent Implantation ', American College of Cardiology. Journal, vol. 68, no. 24, pp. 2622-2632 . https://doi.org/10.1016/j.jacc.2016.09.967
Egholm, G, Kristensen, S D, Thim, T, Olesen, K K W, Madsen, M, Jensen, S E, Jensen, L O, Sørensen, H T, Bøtker, H E & Maeng, M 2016, ' Risk Associated With Surgery Within 12 Months After Coronary Drug-Eluting Stent Implantation ', Journal of the American College of Cardiology, vol. 68, no. 24, pp. 2622-2632 . https://doi.org/10.1016/j.jacc.2016.09.967
Egholm, G, Dalby Kristensen, S, Thim, T, Olesen, K K W, Madsen, M, Jensen, S E, Jensen, L O, Sørensen, H T, Bøtker, H E & Maeng, M 2016, ' Risk Associated With Surgery Within 12 Months After Coronary Drug-Eluting Stent Implantation ', Journal of the American College of Cardiology, vol. 68, no. 24, pp. 2622-2632 . https://doi.org/10.1016/j.jacc.2016.09.967
Egholm, G, Kristensen, S D, Thim, T, Olesen, K K W, Madsen, M, Jensen, S E, Jensen, L O, Sørensen, H T, Bøtker, H E & Maeng, M 2016, ' Risk Associated With Surgery Within 12 Months After Coronary Drug-Eluting Stent Implantation ', Journal of the American College of Cardiology, vol. 68, no. 24, pp. 2622-2632 . https://doi.org/10.1016/j.jacc.2016.09.967
Egholm, G, Dalby Kristensen, S, Thim, T, Olesen, K K W, Madsen, M, Jensen, S E, Jensen, L O, Sørensen, H T, Bøtker, H E & Maeng, M 2016, ' Risk Associated With Surgery Within 12 Months After Coronary Drug-Eluting Stent Implantation ', Journal of the American College of Cardiology, vol. 68, no. 24, pp. 2622-2632 . https://doi.org/10.1016/j.jacc.2016.09.967
BACKGROUND: Guidelines recommend postponing surgery for at least 6 months after treatment with a drug-eluting stent by percutaneous coronary intervention (DES-PCI).OBJECTIVES: The goal of this study was to evaluate the surgical risk associated with D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8817413059c278851eaab7d72ce465b
https://vbn.aau.dk/da/publications/75450194-7ac8-45b6-bfaf-f61ebbf7b89a
https://vbn.aau.dk/da/publications/75450194-7ac8-45b6-bfaf-f61ebbf7b89a